Roche Diabetes Care GmbH (Germany)

Roche Diabetes Care GmbH is a German subsidiary of Roche Holding AG, based in Mannheim, Germany. It forms part of Roche's Diagnostics division and is dedicated to diabetes care, offering blood glucose monitoring systems, test strips, lancing devices, and digital diabetes management platforms. The entity operates within Roche's broader mission to prevent, stop, and cure diseases through integrated diagnostics and pharmaceuticals. Roche itself was founded in Basel, Switzerland, in 1896 by Fritz Hoffmann-La Roche, and has grown into a global healthcare leader with over 100,000 employees and products available in more than 100 countries. Roche Diabetes Care GmbH contributes to this portfolio by focusing on diabetes, a chronic condition that requires continuous monitoring and management. The Mannheim site serves as a key hub for Roche's diabetes care operations, including research, development, and commercial activities. As part of Roche Diagnostics, Roche Diabetes Care GmbH benefits from the group's extensive resources and global reach. Its products are used by people with diabetes, healthcare professionals, and healthcare systems worldwide. The company's offerings include the Accu-Chek brand of blood glucose meters and test strips, which are widely recognized in the diabetes community. In recent years, Roche Diabetes Care has also expanded into digital health solutions, such as the mySugr app and integrated insulin delivery systems, reflecting a broader trend toward connected care. Roche Diabetes Care GmbH operates in a competitive landscape alongside other diabetes care companies, but leverages Roche's reputation for innovation and quality. The entity is not separately listed on any stock exchange; it is a wholly owned subsidiary of Roche Holding AG, which is publicly traded on the SIX Swiss Exchange. Its activities are reported within Roche's Diagnostics division. The company's mission aligns with Roche's overall strategy: to deliver life-changing diagnostics and medicines that address major healthcare challenges. By focusing on diabetes, Roche Diabetes Care GmbH aims to improve outcomes for patients and reduce the burden on healthcare systems. Through continuous innovation and patient-centric solutions, it strives to make a meaningful difference in the lives of people with diabetes.

Roche Diabetes Care GmbH is a subsidiary of Roche Holding AG, a Swiss multinational healthcare company founded in 1896 by Fritz Hoffmann-La Roche in Basel, Switzerland. Roche was one of the first companies established specifically to manufacture scientifically researched pharmaceuticals, and it expanded internationally early on, including to Germany. Over the decades, Roche grew into a global leader in both pharmaceuticals and diagnostics. The diabetes care business of Roche has its roots in the development of blood glucose monitoring technology. Roche entered the diabetes care market through acquisitions and internal development, and the Mannheim site became a key location for this business. The entity Roche Diabetes Care GmbH was established to consolidate Roche's diabetes care activities, particularly after Roche acquired the diabetes care division of Boehringer Mannheim in the 1990s. This acquisition brought the Accu-Chek brand into Roche's portfolio, which remains a flagship product line for blood glucose monitoring. In the 2000s and 2010s, Roche Diabetes Care expanded its offerings to include digital solutions, such as the mySugr app (acquired in 2017) and integrated insulin delivery systems. The company has also focused on connectivity and data management to help patients and healthcare providers better manage diabetes. The Mannheim site serves as a center for research, development, and commercial operations for Roche's diabetes care business. Today, Roche Diabetes Care GmbH operates as part of Roche Diagnostics, contributing to Roche's overall mission to prevent, stop, and cure diseases. It continues to innovate in areas such as continuous glucose monitoring and automated insulin delivery, aiming to improve the lives of people with diabetes worldwide.

• 2017

  Roche acquires mySugr, a digital diabetes management app.

• 1997

  Roche acquires Boehringer Mannheim's diabetes care division, bringing Accu-Chek into its portfolio.

• 1912

  Roche expands internationally, including to Germany.

• 1896

  Roche founded in Basel, Switzerland by Fritz Hoffmann-La Roche.

Integrated diabetes care solutions combining diagnostics, devices, and digital health.

• Accu-Chek blood glucose monitoring systems

  A range of blood glucose meters and test strips for diabetes management.

• mySugr app

  A digital diabetes management application that helps users log and track glucose, meals, and insulin.

1. 1Roche - Doing now what patients need nextroche.com
2. 2Roche | Our historyroche.com
3. 3Roche | About Rocheroche.com
4. 4Roche | Our strategyroche.com
5. 5Roche Diabetes Care GmbH (Germany) - Wikidatawikidata.org